Jean George - Net Worth and Insider Trading

Jean George Net Worth

The estimated net worth of Jean George is at least $683,930 dollars as of 2024-04-27. Jean George is the Director of Acceleron Pharma Inc and owns about 3,750 shares of Acceleron Pharma Inc (XLRN) stock worth over $670,313. Jean George is the Director of Astria Therapeutics Inc and owns about 1,513 shares of Astria Therapeutics Inc (ATXS) stock worth over $13,617. Jean George is also the Director of ZELTIQ Aesthetics Inc and owns about 0 shares of ZELTIQ Aesthetics Inc (ZLTQ) stock worth over $0. Details can be seen in Jean George's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jean George has not made any transactions after 2019-06-28 and currently still holds the listed stock(s).

Transaction Summary of Jean George

To

Jean George Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean George owns 8 companies in total, including ALX Oncology Holdings Inc (ALXO) , Calithera Biosciences Inc (CALA) , and Acceleron Pharma Inc (XLRN) among others .

Click here to see the complete history of Jean George’s form 4 insider trades.

Insider Ownership Summary of Jean George

Ticker Comapny Transaction Date Type of Owner
ALXO ALX Oncology Holdings Inc 2020-07-16 10 percent owner
CALA Calithera Biosciences Inc 2016-06-14 director & 10 percent owner
XLRN Acceleron Pharma Inc 2020-01-22 director
ATXS Astria Therapeutics Inc 2015-06-30 director & 10 percent owner
ZLTQ ZELTIQ Aesthetics Inc 2015-07-22 director
PTLA Portola Pharmaceuticals Inc 2013-05-28 director
CYTT Cyteir Therapeutics Inc 2021-06-17 director
IRON Disc Medicine Inc 2021-02-05 director & 10 percent owner

Jean George Latest Holdings Summary

Jean George currently owns a total of 3 stocks. Among these stocks, Jean George owns 3,750 shares of Acceleron Pharma Inc (XLRN) as of June 28, 2019, with a value of $670,313 and a weighting of 98.01%. Jean George owns 1,513 shares of Astria Therapeutics Inc (ATXS) as of June 30, 2015, with a value of $13,617 and a weighting of 1.99%. Jean George also owns 0 shares of ZELTIQ Aesthetics Inc (ZLTQ) as of November 3, 2014, with a value of $0 and a weighting of 0%.

Latest Holdings of Jean George

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XLRN Acceleron Pharma Inc 2019-06-28 3,750 178.75 670,313
ATXS Astria Therapeutics Inc 2015-06-30 1,513 9.00 13,617
ZLTQ ZELTIQ Aesthetics Inc 2014-11-03 0 56.48 0

Holding Weightings of Jean George


Jean George Form 4 Trading Tracker

According to the SEC Form 4 filings, Jean George has made a total of 1 transactions in Acceleron Pharma Inc (XLRN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acceleron Pharma Inc is the sale of 37,500 shares on June 28, 2019, which brought Jean George around $1 Million.

According to the SEC Form 4 filings, Jean George has made a total of 0 transactions in Astria Therapeutics Inc (ATXS) over the past 5 years. The most-recent trade in Astria Therapeutics Inc is the acquisition of 4,313 shares on June 30, 2015, which cost Jean George around $3 Million.

According to the SEC Form 4 filings, Jean George has made a total of 0 transactions in ZELTIQ Aesthetics Inc (ZLTQ) over the past 5 years. The most-recent trade in ZELTIQ Aesthetics Inc is the sale of 17,483 shares on November 3, 2014, which brought Jean George around $439,697.

Insider Trading History of Jean George

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jean George Trading Performance

GuruFocus tracks the stock performance after each of Jean George's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jean George is -33.74%. GuruFocus also compares Jean George's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jean George within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jean George's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jean George

Average Return

-69.6%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.33 -33.74 -37.84 -69.6 -65.97 -57.17
Relative Return to S&P 500(%) 12.12 -26.8 -37.85 -71.33 -74.34 -66.8

Jean George Ownership Network

Ownership Network List of Jean George

No Data

Ownership Network Relation of Jean George


Jean George Owned Company Details

What does ALX Oncology Holdings Inc do?

Who are the key executives at ALX Oncology Holdings Inc?

Jean George is the 10 percent owner of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include director & President and CEO Jaume Pons , director & 10 percent owner Jason Lettmann , and VP & Finance and CAO Shelly Pinto .

ALX Oncology Holdings Inc (ALXO) Insider Trades Summary

Over the past 18 months, Jean George made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 73,208 shares made by Jaume Pons , a net sale of 10,528 shares made by Shelly Pinto , and a net purchase of 4,400 shares made by Jason Lettmann .

In summary, during the past 3 months, insiders sold 70,000 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 4,400 shares, with a net sale of 65,600 shares. During the past 18 months, 86,228 shares of ALX Oncology Holdings Inc (ALXO) were sold and 4,400 shares were bought by its insiders, resulting in a net sale of 81,828 shares.

ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ALX Oncology Holdings Inc Insider Transactions

No Available Data

Jean George Mailing Address

Above is the net worth, insider trading, and ownership report for Jean George. You might contact Jean George via mailing address: Critical Therapeutics Inc, 60 Westview Street, Lexington Ma 02421.

Discussions on Jean George

No discussions yet.